Literature DB >> 9632569

Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.

M Roberts1, J Li, A Bacon, S Chatfield.   

Abstract

We have found the in vivo-regulated nirB promoter (PnirB) to be effective for directing expression of a number of antigens in salmonella in vivo. We wished to determine if other in vivo-regulated promoters have utility for antigen expression in salmonella and to compare the effectiveness of these promoters with that of PnirB. To this end, we have devised a scheme that allows the promoter element of the PnirB-fragment C plasmid pTETnir15 to be swapped with other promoters of interest. We demonstrate the usefulness of this system by replacing PnirB with PhtrA to create plasmid pTEThtrA1. htrA is a stress response gene that is required for virulence of salmonella in mice and survival within macrophages. Expression of fragment C in Salmonella typhimurium BRD509 (aroA aroD) harboring pTEThtrA1 (strain BRD937) correlated with growth temperature in vitro. A comparison was made of the immune responses to fragment C elicited in mice immunized orally with BRD937 or BRD847 (BRD509/pTETnir15) or subcutaneously with purified fragment C plus alhydrogel. High levels of anti-fragment C antibodies that persisted for at least 12 weeks were present in all groups of mice. Vaccination with BRD937 was the most effective means of immunization: the serum immunoglobulin G (IgG), IgA, and IgM anti-fragment C titers were higher in the BRD937-immunized mice throughout the duration of the study than in mice in the other groups. The kinetics of the serum anti-fragment C responses were different in different groups. The response was most rapid in the BRD937 group, with the titers almost at peak levels at 2 weeks postimmunization. Only the mice immunized with BRD937 or BRD847 developed an intestinal IgA response to fragment C. Again, the response was superior in the BRD937 group. The peak of the intestinal response was delayed with respect to the serum response. Analysis of the IgG subtype response to fragment C revealed a dominant IgG2a response in the salmonella-immunized mice, indicating a type 1 helper T-cell response to fragment C, whereas the major subtype in the group parenterally immunized with fragment C plus alhydrogel was IgG1. The IgG1/IgG2a ratio was much higher in sera of BRD937-immunized mice than in sera of BRD847-immunized mice. At 15 to 20 weeks after immunization, the mice immunized with BRD937 or BRD847 were solidly immune to tetanus toxin and salmonella. The immune responses to fragment C seen in mice immunized with BRD937 are the strongest we have observed and indicate that the htrA promoter may be very useful for expressing foreign antigens in salmonella vaccine strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632569      PMCID: PMC108316     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase.

Authors:  B Lipinska; M Zylicz; C Georgopoulos
Journal:  J Bacteriol       Date:  1990-04       Impact factor: 3.490

2.  Characterization of degP, a gene required for proteolysis in the cell envelope and essential for growth of Escherichia coli at high temperature.

Authors:  K L Strauch; K Johnson; J Beckwith
Journal:  J Bacteriol       Date:  1989-05       Impact factor: 3.490

3.  Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli.

Authors:  N F Fairweather; V A Lyness; D J Maskell
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

4.  Sequence analysis and regulation of the htrA gene of Escherichia coli: a sigma 32-independent mechanism of heat-inducible transcription.

Authors:  B Lipinska; S Sharma; C Georgopoulos
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

5.  Identification, characterization, and mapping of the Escherichia coli htrA gene, whose product is essential for bacterial growth only at elevated temperatures.

Authors:  B Lipinska; O Fayet; L Baird; C Georgopoulos
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

6.  Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains.

Authors:  R A Strugnell; D Maskell; N Fairweather; D Pickard; A Cockayne; C Penn; G Dougan
Journal:  Gene       Date:  1990-03-30       Impact factor: 3.688

7.  Protease Do is essential for survival of Escherichia coli at high temperatures: its identity with the htrA gene product.

Authors:  J H Seol; S K Woo; E M Jung; S J Yoo; C S Lee; K J Kim; K Tanaka; A Ichihara; D B Ha; C H Chung
Journal:  Biochem Biophys Res Commun       Date:  1991-04-30       Impact factor: 3.575

8.  Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.

Authors:  D M Yang; N Fairweather; L L Button; W R McMaster; L P Kahl; F Y Liew
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

9.  The ability of Salmonella to enter mammalian cells is affected by bacterial growth state.

Authors:  C A Lee; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems.

Authors:  D J Maskell; K J Sweeney; D O'Callaghan; C E Hormaeche; F Y Liew; G Dougan
Journal:  Microb Pathog       Date:  1987-03       Impact factor: 3.738

View more
  22 in total

Review 1.  Bacterial infectious disease control by vaccine development.

Authors:  Roy Curtiss
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  Stabilization of a plasmid coding for a heterologous antigen in Salmonella enterica serotype typhi vaccine strain CVD908-htrA by using site-specific recombination.

Authors:  Jonathan C Stephens; Michael J Darsley; Arthur K Turner
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Comparison of abilities of Salmonella enterica serovar typhimurium aroA aroD and aroA htrA mutants to act as live vectors.

Authors:  M Roberts; S Chatfield; D Pickard; J Li; A Bacon
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  In vivo visualization of bacterial colonization, antigen expression, and specific T-cell induction following oral administration of live recombinant Salmonella enterica serovar Typhimurium.

Authors:  D Bumann
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.

Authors:  James E Galen; Jin Yuan Wang; Jose A Carrasco; Scott A Lloyd; Gabriela Mellado-Sanchez; Jovita Diaz-McNair; Olga Franco; Amanda D Buskirk; James P Nataro; Marcela F Pasetti
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

6.  Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.

Authors:  Shifeng Wang; Yuhua Li; Huoying Shi; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

7.  Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines.

Authors:  M Sydenham; G Douce; F Bowe; S Ahmed; S Chatfield; G Dougan
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.

Authors:  Wei Xin; Soo-Young Wanda; Yuhua Li; Shifeng Wang; Hua Mo; Roy Curtiss
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

9.  Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.

Authors:  Alejandra V E Capozzo; Lilian Cuberos; Myron M Levine; Marcela F Pasetti
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Construction, characterization, and immunogenicity of an attenuated Salmonella enterica serovar typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoter.

Authors:  Huaiqing Chen; Dieter M Schifferli
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.